Your session is about to expire
← Back to Search
Computerized Ventilator Management for Respiratory Diseases (REDvent Trial)
REDvent Trial Summary
This trial is testing whether a new computer-based approach can reduce ventilator-induced respiratory muscle weakness in critically ill children. The primary clinical outcome is length of weaning (time from first Spontaneous Breathing Trial (SBT) until successful passage of an SBT or extubation (whichever comes first)).
REDvent Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowREDvent Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.REDvent Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot be weaned off support due to severe health issues.I am on a ventilator due to lung disease and need a high level of oxygen.I started using a breathing machine less than 48 hours ago, or less than 72 hours ago if I was transferred.I don't have conditions that prevent the use of an esophageal catheter.I am between 1 month and 18 years old.
- Group 1: REDvent-weaning
- Group 2: Control-weaning
- Group 3: Control-acute
- Group 4: REDvent-acute
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I meet the screening requirements for this clinical trial?
"This study is looking for 276 young patients aged between 1 month and 18 years that suffer from respiratory diseases. Importantly, these children must be within 48 hours of starting invasive mechanical ventilation (though 72 hours is allowed for those transferred from another institution)."
Does this test only include those under 45, or are older patients eligible as well?
"The age restriction for this clinical study is 30 days to 18 years old."
Share this study with friends
Copy Link
Messenger